NeOnc Technologies Holdings, Inc. (NTHI)
NASDAQ: NTHI · Real-Time Price · USD
8.61
+0.55 (6.82%)
Jan 22, 2026, 12:59 PM EST - Market open
NTHI Employees
NeOnc Technologies Holdings had 8 employees as of December 31, 2023.
Employees
8
Change
n/a
Growth
n/a
Revenue / Employee
$7,499
Profits / Employee
-$6,109,386
Market Cap
167.67M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2023 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 188 |
| Innate Pharma | 181 |
| Prelude Therapeutics | 131 |
| Rani Therapeutics Holdings | 106 |
| Nkarta | 105 |
| Vaxart | 105 |
| Tenaya Therapeutics | 97 |
| Surrozen | 41 |
NTHI News
- 12 days ago - Stonegate Capital Partners Initiates Coverage on NeOnc Technologies Holdings, Inc. (NTHI) - Newsfile Corp
- 5 weeks ago - NeOnc Technologies Reports Updated Clinical Results - GlobeNewsWire
- 7 weeks ago - NeOnc Technologies (Nasdaq: NTHI) Announces AI-Driven Findings Showing Ultrasound Enhances the Potency of an Already Effective NEO100 in Treating Primary and Metastatic Brain Tumors - GlobeNewsWire
- 2 months ago - NeOnc Technologies Completes Enrollment in Pivotal NEO100 Phase2a Trial for IDH-1 mutant Recurrent High‑Grade Glioma and Expects Interim Data Readout in SixMonths (Q22026) - GlobeNewsWire
- 2 months ago - NeOnc Technologies (Nasdaq: NTHI) to Host Investor Conference Call to Present Data Updates from Ongoing NEO100-1 Phase 1/2a Clinical Trial and Compassionate Use Program - GlobeNewsWire
- 3 months ago - NeOnc Technologies: From Survival Mode To Expansion Mode - Seeking Alpha
- 3 months ago - NeOnc Technologies' Subsidiary, NuroMENA, Signs Master Services Agreement with M42's IROS and Expands Board of Directors - GlobeNewsWire
- 4 months ago - NeOnc Technologies Appoints Renowned Neuro-Oncologist Dr. Henry S. Friedman to Scientific Advisory Board - GlobeNewsWire